Welcome to InnoAlliance. We are committed to protecting the security of your
personal information and respecting your privacy rights. This statement aims
to introduce you to the types of cookies used on our website and their
purposes, as well as provide some guidance on how to manage your cookie
settings. For more information, please refer to our
Cookie Policy.
Reject
Accept
We want to hear from you
Together, We Can!
A bioanalytical CRO located in the heart of BioTech Bay and Silicon Valley
InnoAlliance,a subsidiary company of InnoStar (Stock code: 688710), is a contract research organization (CRO) specializing in regulated and discovery bioanalysis and biomarker testing.
We support the clinical pharmacokinetics, immunogenicity, pharmacodynamics, and toxicokinetics of innovative drugs covering a wide range of drug categories.
InnoAlliance accompanies partners through the new drug R&D, in the full life cycle of from discovery, nonclinical studies and clinical studies, to post-marketing drug monitoring.
InnoAlliance leverages state-of-art facilities and advanced technology platforms to perfect one-stop bioanalytical solutions to a wide range of drug modalities.